Sort   by:  
 Page size 
ProteomicsCSF prognostic markers for amyotrophic lateral sclerosis: a proteomic study
The rate of disease progression widely varies between patients with amyotrophic lateral sclerosis (ALS). Prognostic assessment using biomarkers is highly preferred for planning medical care and improving the design of clinical trials. Therefore, the current study aimed to assess prognostic biomarker...
ORGANISM(S): Homo sapiens (Human) 
2024-10-31 | PXD057276 | Pride
Cerebrospinal fluid Progression rate Amyotrophic lateral sclerosis Biomarker 
UnknownBlood DNA virome associates with autoimmune diseases and COVID-19.
Not available
S-EPMC11735405 | biostudies-literature
UnknownSingle-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity.
Not available
S-EPMC10181941 | biostudies-literature
UnknownThe whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force.
Not available
S-EPMC9395416 | biostudies-literature
UnknownDeciphering state-dependent immune features from multi-layer omics data at single-cell resolution.
Not available
S-EPMC12339405 | biostudies-literature
UnknownQuantification of escape from X chromosome inactivation with single-cell omics data reveals heterogeneity across cell types and tissues.
Not available
S-EPMC11406184 | biostudies-literature
Sort   by:  
 Page size